PFM Health Sciences, LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001442756

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallHealth TiltHigh Turnover how tags are computed

Q3 2026 · 81 positions · Total reported value $978.49M · Top-10 concentration 35.1% · Updated 2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

Turnover: 75.8% · 24 new · 28 cut · 39 exited

Active Share (vs S&P 500): 96.6% · vs QQQ: 99.7% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -4.9% · vs SPY -7.0% · Prev Value $1.14B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): +2.3% · vs SPY +0.2% · Latest Value $978.49M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q3 2026 13F filing, PFM Health Sciences, LP disclosed 81 equity positions with a combined reported value of $978.49M. The filing implies a moderately concentrated portfolio: its ten largest positions account for 35.1% of reported value. HoldingsHub classifies the profile as Small / Health Tilt / High Turnover.

The largest disclosed positions as of Q3 2026 were ASND ($52.14M), AXSM ($40.95M), XBI ($38.55M). By sector, the heaviest allocations are Health Care 82.7%, Industrials 6.2%. Versus the prior quarter, allocation shifted toward Other (+8.2pp), Technology (+2.2pp) and away from Consumer Staples (-1.2pp), Health Care (-10.2pp).

Versus the prior quarter, PFM Health Sciences, LP opened 24 new positions, trimmed 28 and fully exited 39, a turnover rate of 75.8% of positions. The portfolio's overlap with the prior quarter was 48% of names.

The largest new positions opened in Q3 2026 were XBI ($38.55M), SPY ($24.73M), CNMD ($14.99M).

Of the 39 positions fully exited versus the prior quarter, the largest were PEN ($19.01M), SYK ($17.83M), MTD ($17.05M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2026)

  • XBI SPDR SERIES TRUST · $38.55M
  • SPY STATE STR SPDR S&P 500 ETF T · $24.73M
  • CNMD CONMED CORP · $14.99M
  • TEVA TEVA PHARMACEUTICAL INDS LTD · $14.07M
  • ZBH ZIMMER BIOMET HOLDINGS INC · $13.81M
  • IWM ISHARES TR · $12.59M
  • VEEV VEEVA SYS INC · $11.33M
  • GMAB GENMAB A/S · $11.19M

Fully Exited (vs previous quarter)

  • PEN PENUMBRA INC · prev qtr: $19.01M
  • SYK STRYKER CORPORATION · prev qtr: $17.83M
  • MTD METTLER TOLEDO INTERNATIONAL · prev qtr: $17.05M
  • MRK MERCK & CO INC · prev qtr: $16.33M
  • LNTH LANTHEUS HLDGS INC · prev qtr: $16.24M
  • COO COOPER COS INC · prev qtr: $15.84M
  • ACHC ACADIA HEALTHCARE COMPANY IN · prev qtr: $15.50M
  • ORKA ORUKA THERAPEUTICS INC · prev qtr: $15.12M

Insider Transactions (Form 4)

Latest PFM Health Sciences, LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

PFM Health Sciences, LP is an SEC-registered 13F filer based in San Francisco, CA, United States. As of Q2 2026 it reported 96 US equity positions with a combined value of $1.14B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: SAN FRANCISCO, CA, United States
  • SEC registration: 801-69012 (status: Approved), registered 2008-04-10
  • Regulatory AUM (Form ADV): $1.27B as of 2026-03-31
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 4 private funds, of which 2 hedge funds
  • Website: pfmhealthsciences.com

Portfolio Structure

  • 96 positions · $1.14B reported value (Q2 2026)
  • Top 10 holdings = 34.6% of reported value
  • Largest position: ASND (ASCENDIS PHARMA A/S) at 5.4%
  • Average position size: $11.89M

Sector Tilt

  • Health Care 92.9%
  • Industrials 5.1%
  • Consumer Staples 1.2%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 32 new, 24 added, 40 reduced, 14 exited

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 82.7%
Technology 3.0%
Other 8.2%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 228.87K $52.14M 5.33%
5.33%
Reduce
2 222.10K $40.95M 4.18%
4.18%
Add
3 244.50K $38.55M 3.94%
3.94%
New
4 69.24K $37.52M 3.83%
3.83%
Add
5 127.29K $32.53M 3.33%
3.33%
Add
6 320.33K $32.06M 3.28%
3.28%
Add
7 25.08K $29.01M 2.96%
2.96%
Reduce
8 204.34K $28.98M 2.96%
2.96%
Reduce
9 741.86K $26.60M 2.72%
2.72%
Add
10 32.42K $24.73M 2.53%
2.53%
New
11 365.57K $24.05M 2.46%
2.46%
Add
12 31.98K $21.59M 2.21%
2.21%
Add
13 102.11K $20.96M 2.14%
2.14%
Reduce
14 88.93K $20.59M 2.10%
2.10%
Reduce
15 51.08K $19.49M 1.99%
1.99%
Reduce
16 43.92K $19.30M 1.97%
1.97%
Reduce
17 49.67K $18.23M 1.86%
1.86%
Reduce
18 176.43K $17.44M 1.78%
1.78%
Add
19 258.82K $17.06M 1.74%
1.74%
Add
20 822.89K $16.57M 1.69%
1.69%
Add
21 499.84K $15.41M 1.57%
1.57%
Reduce
22 324.25K $14.99M 1.53%
1.53%
New
23 28.88K $14.55M 1.49%
1.49%
Reduce
24 116.07K $14.51M 1.48%
1.48%
Add
25 355.25K $14.07M 1.44%
1.44%
New
26 155.43K $13.81M 1.41%
1.41%
New
27 151.82K $13.11M 1.34%
1.34%
Reduce
28 335.10K $12.75M 1.30%
1.30%
Add
29 45.30K $12.59M 1.29%
1.29%
New
30 39.68K $11.33M 1.16%
1.16%
New
31 313.68K $11.19M 1.14%
1.14%
New
32 188.79K $11.03M 1.13%
1.13%
New
33 96.59K $10.98M 1.12%
1.12%
Add
34 36.48K $10.63M 1.09%
1.09%
Reduce
35 169.56K $10.53M 1.08%
1.08%
Add
36 109.55K $10.39M 1.06%
1.06%
Reduce
37 567.10K $10.32M 1.05%
1.05%
Add
38 1.13M $10.26M 1.05%
1.05%
Reduce
39 45.66K $10.12M 1.03%
1.03%
New
40 150.03K $9.82M 1.00%
1.00%
Add
41 578.98K $9.43M 0.96%
0.96%
Add
42 55.08K $9.35M 0.96%
0.96%
Add
43 50.25K $8.54M 0.87%
0.87%
Reduce
44 190.91K $8.52M 0.87%
0.87%
New
45 282.43K $8.22M 0.84%
0.84%
Add
46 344.95K $7.72M 0.79%
0.79%
Add
47 20.28K $7.66M 0.78%
0.78%
Add
48 235.81K $7.64M 0.78%
0.78%
Reduce
49 42.41K $7.56M 0.77%
0.77%
Add
50 127.60K $7.24M 0.74%
0.74%
Reduce

Holdings Prediction Model

Predicts next-quarter Top-10 holdings and weights from the fund's own historical trading轨迹 (add / reduce / hold) plus each stock's price momentum and relative volume. Strictly no look-ahead: a prediction for quarter T+1 uses only data through quarter T. Weights are shares of the modelled portfolio.

The next-quarter predicted Top 10 (2026-Q4) is shown in the «Latest Q · Forecast» tab above, in the same holdings format. That view is for logged-in accounts: 3 views per day on Free, unlimited on Gold/Diamond.

Latest-Quarter Accuracy (2026-Q3)

P 60% R 60% F1 60% (modelled on 2026-Q2; 6/10 hit)

Low-confidence forecast This fund replaces about 36% of its Top-10 each quarter and backtests at F1 64% (threshold 80%). Holdings in high-turnover portfolios cannot be forecast from their own history; the figures below are illustrative.

Historical Backtest (11 quarters)

Avg precision 64% · recall 64% · F1 64% · avg rank error 2.8 · Top-10 turnover 36%

Quarter Prec. Recall F1 Predicted Top 10 Actual Top 10
2024-Q1 70% 70% 70% LLY · MRK · VRTX · ABBV · EW · HUM · BDX · MCK · THC · KRTX LLY · MRK · ABBV · EW · VRTX · THC · MCK · TLT · CNC · ISRG
2024-Q2 80% 80% 80% LLY · MRK · ABBV · EW · VRTX · THC · MCK · ISRG · TLT · CNC LLY · CYTK · QQQ · THC · MRK · VRTX · ABBV · EW · ISRG · MCK
2024-Q3 80% 80% 80% LLY · QQQ · CYTK · THC · MRK · VRTX · ISRG · ABBV · EW · MCK LLY · THC · CYTK · ABBV · VRTX · ISRG · MRK · HCA · UHS · MCK
2024-Q4 50% 50% 50% LLY · THC · CYTK · ABBV · ISRG · VRTX · MRK · HCA · UNH · ACHC LLY · IEF · THC · ABBV · MCK · VRTX · ISRG · AXSM · PEN · ARGX
2025-Q1 80% 80% 80% LLY · IEF · THC · ABBV · MCK · VRTX · ISRG · AXSM · PEN · UHS LLY · ABBV · THC · MCK · AXSM · XLV · VRTX · ISRG · PEN · SLNO
2025-Q2 70% 70% 70% LLY · XLV · ABBV · AXSM · MCK · THC · VRTX · SLNO · PEN · ISRG LLY · THC · MCK · AXSM · ISRG · PEN · SLNO · CVS · OM · DHR
2025-Q3 60% 60% 60% LLY · THC · MCK · AXSM · ISRG · PEN · CVS · SLNO · OM · DHR LLY · THC · XBI · AXSM · MCK · PEN · UTHR · ISRG · EW · HCA
2025-Q4 50% 50% 50% LLY · THC · XBI · AXSM · MCK · PEN · UTHR · ISRG · EW · COR THC · LLY · AXSM · PEN · UTHR · BBIO · ADMA · NBIX · GKOS · TMO
2026-Q1 60% 60% 60% THC · LLY · PEN · AXSM · UTHR · NBIX · TMO · ADMA · BBIO · GKOS THC · LLY · XBI · PEN · AXSM · XLV · JAZZ · NBIX · GKOS · CNTA
2026-Q2 50% 50% 50% THC · XBI · LLY · PEN · AXSM · XLV · JAZZ · NBIX · GKOS · INBX ASND · AXSM · LLY · JAZZ · HUM · UNH · NBIX · INBX · UTHR · RVMD
2026-Q3 ★ 60% 60% 60% ASND · AXSM · LLY · JAZZ · HUM · UNH · NBIX · INBX · RVMD · UTHR ASND · AXSM · XBI · UTHR · THC · INBX · LLY · NBIX · INDV · SPY

★ = latest filed quarter (predicted vs actual). Recall = share of the real Top 10 caught by the model; precision = share of the predicted Top 10 that were real.

Barra Factor Attribution

The disclosed long US equity book from the 2026-Q3 13F is held at its report-date weights and decomposed over 2026-09-30 ~ 2026-11-13. The model uses 16 Barra style factors plus GICS sector dummies, WLS cross-sectional factor returns and an EWMA factor covariance for risk. The “portfolio” is the visible 13F book, not the fund's true NAV.

13F periodQ3 2026 Attribution quarterQ4 2026 (in progress) Window2026-09-30 → 2026-11-13 Trading days32 Holdings26 Model coverage100.0%

The quarter is not complete yet; the window ends at the latest available price date, 2026-11-13, and will update as prices arrive.

Portfolio return+6.87%Buy & hold
QQQ synthetic benchmark-13.72%Liquidity weighted
Excess return+20.58%vs benchmark
Barra annualised vol18.3%Model estimate
Realised vol19.1%Annualised in window
Weighted beta0.64Raw exposure
Factor / specific risk75% / 25%Share of variance
Top-10 concentration68.5%Of reported value
Portfolio value (start = 100)77.986.294.5102.8111.110-0110-2311-13PFM Health Sciences, LPQQQ syntheticLiquid universe EW
Start = 100. Red = portfolio, dark = QQQ synthetic benchmark, dashed grey = equal-weight model universe.

1. Performance

Metric Value Note
Portfolio return (buy & hold)+6.87%Disclosed long book
QQQ synthetic benchmark-13.72%Liquidity-weighted constituents
Model universe, equal weight+0.30%Opportunity-cost reference
Excess return+20.58%Portfolio − benchmark
Arithmetic return sum+6.87%Difference vs compounded is the cross term
Weighted raw beta0.64Weighted holding betas
Realised volatility (annualised)19.07%Daily returns in window
Barra model volatility (annualised)18.28%Factor + specific
Factor share of variance74.6%Barra factors
Specific share of variance25.4%Stock residuals
Reported value$339.3M13F long US equity

2. Return attribution

The +6.87% arithmetic return splits into style factors, sector factors and specific return; the table is sorted by contribution.

Factor group Factors Contribution Share of |return|
Size & Liquidity 6 +1.90% 27.7%
Momentum & Growth 3 -1.55% -22.5%
Volatility & Tail Risk 7 +5.47% 79.5%
Industry 12 +7.40% 107.7%
Specific 1 -6.35% -92.5%
Return attribution (style + industry, %)-6.4-3.2+0.0+3.2+6.4Industrials+0.32Growth+0.33Mid Cap-0.48Non-linear Size+0.59Leverage (Downside Vol)+0.76Beta-1.13Other+1.19Momentum-1.78Turnover+1.93Residual Volatility+1.99Kurtosis+2.70Skewness-2.84Historical Volatility+4.15Health Care+5.90
Factor Type Exposure Factor return Contribution Share of |return|
Health Care Industry +0.73 +8.12% +5.90% 85.8%
Historical Volatility Style -0.32 -12.86% +4.15% 60.4%
Kurtosis Style +0.39 +6.97% +2.70% 39.3%
Residual Volatility Style +0.75 +2.66% +1.99% 29.0%
Turnover Style -0.40 -4.77% +1.93% 28.1%
Other Industry +0.12 +10.06% +1.19% 17.3%
Leverage (Downside Vol) Style -0.41 -1.82% +0.76% 11.0%
Non-linear Size Style +0.65 +0.91% +0.59% 8.6%
Growth Style +0.21 +1.57% +0.33% 4.8%
Industrials Industry +0.16 +2.04% +0.32% 4.6%
Size Style -0.05 -1.83% +0.09% 1.2%
Short-term Reversal Style -0.13 +0.79% -0.10% -1.4%
Max Drawdown Style +0.08 -1.96% -0.16% -2.3%
Amihud Illiquidity Style +0.57 -0.40% -0.23% -3.3%
Mid Cap Style +0.28 -1.69% -0.48% -7.0%
Beta Style -0.23 +4.85% -1.13% -16.4%
Momentum Style +0.53 -3.34% -1.78% -25.9%
Skewness Style +0.67 -4.21% -2.84% -41.3%
Specific Specific — — -6.35% -92.5%

3. Risk attribution

Annualised volatility is 18.28%; factor risk explains 74.6% of variance and specific risk 25.4%. A negative variance contribution means the factor is negatively correlated with the rest of the book and acts as a partial hedge.

Risk attribution (share of variance, %)-48.2-24.1+0.0+24.1+48.2Beta-3.38Non-linear Size-1.31Growth+0.81Mid Cap+0.93Leverage (Downside Vol)+1.49Skewness+1.70Kurtosis+2.02Residual Volatility+2.15Historical Volatility+3.00Industrials+5.73Momentum+7.94Other+8.65Specific+25.44Health Care+44.59
Factor Type Exposure Share of variance Vol contribution Share of vol
Health Care Industry +0.73 44.6% +8.15% 8.2%
Specific Specific — 25.4% +4.65% 4.7%
Other Industry +0.12 8.7% +1.58% 1.6%
Momentum Style +0.53 7.9% +1.45% 1.4%
Industrials Industry +0.16 5.7% +1.05% 1.1%
Historical Volatility Style -0.32 3.0% +0.55% 0.6%
Residual Volatility Style +0.75 2.1% +0.39% 0.4%
Kurtosis Style +0.39 2.0% +0.37% 0.4%
Skewness Style +0.67 1.7% +0.31% 0.3%
Leverage (Downside Vol) Style -0.41 1.5% +0.27% 0.3%
Mid Cap Style +0.28 0.9% +0.17% 0.2%
Growth Style +0.21 0.8% +0.15% 0.1%
Amihud Illiquidity Style +0.57 0.7% +0.14% 0.1%
Turnover Style -0.40 0.3% +0.06% 0.1%
Size Style -0.05 0.3% +0.05% 0.1%
Short-term Reversal Style -0.13 -0.5% -0.09% -0.1%
Max Drawdown Style +0.08 -0.7% -0.13% -0.1%
Non-linear Size Style +0.65 -1.3% -0.24% -0.2%
Beta Style -0.23 -3.4% -0.62% -0.6%

4. Style exposures

Standardised z-scores; positive means the book leans toward that style versus the model universe, negative means underweight.

Style exposures (z-score)-0.9-0.10.71.62.4Max DrawdownKurtosisSkewnessLeverage (Downside Vol)GrowthTurnoverAmihud IlliquidityLiquidityHistorical VolatilityResidual VolatilityShort-term ReversalMomentumBetaMid CapNon-linear SizeSizePortfolioQQQ benchmark
Style factor Portfolio QQQ benchmark Difference
Size -0.05 +2.10 -2.15
Non-linear Size +0.65 +1.68 -1.03
Mid Cap +0.28 +0.13 +0.16
Beta -0.23 +1.29 -1.53
Momentum +0.53 +0.72 -0.18
Short-term Reversal -0.13 -0.64 +0.52
Residual Volatility +0.75 -0.40 +1.15
Historical Volatility -0.32 +0.86 -1.18
Liquidity +0.03 +0.11 -0.09
Amihud Illiquidity +0.56 +1.16 -0.59
Turnover -0.41 +0.21 -0.61
Growth +0.21 +0.58 -0.37
Leverage (Downside Vol) -0.41 +0.14 -0.56
Skewness +0.67 +0.24 +0.44
Kurtosis +0.39 +0.21 +0.17
Max Drawdown +0.08 -0.08 +0.17

5. Industry allocation & Brinson

Industry allocation (weight, %)-7.414.736.858.981.0Information TechnologyCommunication ServicesUtilitiesConsumer StaplesConsumer DiscretionaryOtherIndustrialsHealth CarePortfolioQQQ benchmark
Sector Portfolio Benchmark Portfolio ret Benchmark ret Allocation Selection Interaction Total
Information Technology 0.0% 73.6% +0.00% -19.18% +4.32% +14.12% -14.12% +14.12%
Health Care 72.6% 1.7% +8.61% +9.16% +15.93% -0.01% -0.39% +6.10%
Communication Services 0.0% 2.6% +0.00% -15.54% +0.06% +0.41% -0.41% +0.41%
Other 11.8% 0.0% +1.91% +0.00% +1.57% +0.00% +0.23% +0.23%
Utilities 0.0% 0.8% +0.00% +11.58% -0.20% -0.09% +0.09% -0.09%
Consumer Staples 0.0% 0.8% +0.00% +15.58% -0.24% -0.13% +0.13% -0.13%
Industrials 15.6% 11.1% +3.01% +7.16% +0.91% -0.46% -0.19% -0.33%
Consumer Discretionary 0.0% 8.8% +0.00% +5.56% -1.66% -0.49% +0.49% -0.49%
Total +20.59% +13.31% -14.13% +19.77%

6. Holdings & contribution

Symbol Name Sector Weight Return Contribution QoQ
UTHR UNITED THERAPEUTICS CORP DEL Health Care 11.06% +9.09% +1.01% Add
LLY ELI LILLY & CO Health Care 8.55% +24.75% +2.12% Reduce
SPY STATE STR SPDR S&P 500 ETF T Other 7.29% +2.16% +0.16% New
BBIO BRIDGEBIO PHARMA INC Health Care 7.09% +19.00% +1.35% Add
TMO THERMO FISHER SCIENTIFIC INC Industrials 6.36% +3.73% +0.24% Add
RVMD REVOLUTION MEDICINES INC Health Care 6.18% -16.06% -0.99% Reduce
HUM HUMANA INC Health Care 5.74% +17.93% +1.03% Reduce
WAT WATERS CORP Industrials 5.69% +4.75% +0.27% Reduce
UNH UNITEDHEALTH GROUP INC Health Care 5.37% +11.00% +0.59% Reduce
ABT ABBOTT LABORATORIES Health Care 5.14% +9.80% +0.50% Add
MDGL MADRIGAL PHARMACEUTICALS INC Health Care 4.29% -15.19% -0.65% Reduce
IWM ISHARES TR Other 3.71% +1.24% +0.05% New
EXEL EXELIXIS INC Health Care 3.25% +18.13% +0.59% New
CNC CENTENE CORP DEL Health Care 3.10% +14.73% +0.46% Add
DHR DANAHER CORP DEL Industrials 2.98% +5.18% +0.15% New
ICLR ICON PUB LTD CO Health Care 2.52% +14.51% +0.36% Reduce
GH GUARDANT HEALTH INC Health Care 2.23% -14.95% -0.33% Add
WST WEST PHARMACEUTICAL SVSC INC Health Care 1.78% +12.31% +0.22% Reduce
GEHC GE HEALTHCARE TECHNOLOGIES I Health Care 1.61% +27.00% +0.43% New
HCA HCA HEALTHCARE INC Health Care 1.22% +16.95% +0.21% Add
Contribution rank Symbol Sector Weight Return Contribution
1 LLY Health Care 8.55% +24.75% +2.12%
2 BBIO Health Care 7.09% +19.00% +1.35%
3 HUM Health Care 5.74% +17.93% +1.03%
4 UTHR Health Care 11.06% +9.09% +1.01%
5 UNH Health Care 5.37% +11.00% +0.59%
6 EXEL Health Care 3.25% +18.13% +0.59%
7 ABT Health Care 5.14% +9.80% +0.50%
8 CNC Health Care 3.10% +14.73% +0.46%
9 GPCR Health Care 0.61% -36.04% -0.22%
10 GH Health Care 2.23% -14.95% -0.33%
11 TWST Health Care 0.86% -42.25% -0.36%
12 MDGL Health Care 4.29% -15.19% -0.65%
13 RVMD Health Care 6.18% -16.06% -0.99%

7. Conclusions

  1. Over the attribution window 2026-09-30 → 2026-11-13 (32 trading days), the reported portfolio returned +6.87%, versus -13.72% for the QQQ synthetic benchmark — an excess of +20.58%.
  2. Return attribution: the largest positive style/industry contributions came from Health Care +5.90%, Historical Volatility +4.15%, Kurtosis +2.70%; the largest drags came from Skewness -2.84%, Momentum -1.78%, Beta -1.13%. Specific (stock-level) return contributed -6.35%.
  3. Risk attribution: Barra model volatility is 18.28% annualised; factor risk explains 75% of variance and specific risk 25%. The largest factor risk sources are Health Care 44.6%, Other 8.7%, Momentum 7.9%.
  4. Style tilt: size -0.05, momentum +0.53, volatility -0.32, liquidity +0.03; the weighted raw beta is 0.64. Positive z-scores mean the portfolio leans toward that style versus the cross-section.
  5. Industry: the largest overweight versus the benchmark is Health Care (+70.9 pp), the largest underweight is Information Technology (-73.6 pp). Allocation contributed +20.59%, selection +13.31% and interaction -14.13%.
  6. Concentration: the top-10 positions are 68.5% of the attributed portfolio and the model covers 100.0% of its value with full style exposures. This is a high-conviction, long-only 13F book — not the fund's complete NAV.
Methodology & caveats
  • 13F discloses long US equity (including some options) only; cash, shorts and non-US positions are absent. This is not the fund's true NAV.
  • Weights are the report-date reported values and stay fixed over the window (buy & hold); intra-quarter trading and flows are not captured.
  • Factor exposures are measured at quarter end and held through the next quarter; style factors are cross-sectionally orthogonalised and read as incremental exposures.
  • The database has no share-count data, so size and liquidity use dollar volume (price × volume) as a proxy; Size is closer to “traded-value scale”.
  • Factor returns come from a WLS cross-sectional regression on the model universe; risk is annualised, and some factor variance contributions can be negative.
  • 13F filings lag by up to 45 days, so the stretch from the report date to the filing date was not actionable in real time.
  • Sector mapping uses one consistent GICS level-1 scheme for both the portfolio and the benchmark.

FAQ

What did PFM Health Sciences, LP buy in 2026-Q3?

In its 2026-Q3 13F filing, PFM Health Sciences, LP reported 81 equity positions worth $978.49M in aggregate; its largest disclosed positions were ASND ($52.14M), AXSM ($40.95M), XBI ($38.55M).

How large is PFM Health Sciences, LP's portfolio?

PFM Health Sciences, LP reported $978.49M of long equity holdings across 81 positions as of 2026-Q3. Top-10 holdings account for 35.1% of reported value.

What is PFM Health Sciences, LP's investment style?

HoldingsHub classifies the portfolio as Small / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/pfm-health-sciences/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →